Docking studies of Nickel-Peptide deformylase (PDF) inhibitors: Exploring the new binding pockets

Biophysical Chemistry

Volumn 122, Issue 1, 2006, Pages 43-49

  Wang, Qiang ^a   Zhang, Datong ^a   Wang, Jianwu ^a   Cai, Zhengting ^a   Xu, Weiren ^b  

^a SHANDONG UNIVERSITY   (China)

^b TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

Author keywords

Binding pocket; Docking; Peptide deformylase (PDF) inhibitor; Protein ligand interaction

Indexed keywords

NICKEL; NICKEL PEPTIDE DEFORMYLASE INHIBITOR; PEPTIDE DEFORMYLASE; PEPTIDE DEFORMYLASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER PROGRAM; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG BINDING; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG TARGETING; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMIDOHYDROLASES; BINDING SITES; ENZYME INHIBITORS; HYDROXAMIC ACIDS; HYDROXYLAMINES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NICKEL; PROTEIN CONFORMATION; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33744979775     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2006.02.009     Document Type: Article

References (29)

1. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria - a report on the Rockefeller University workshop. N. Engl. J. Med. 330 (1994) 1247-1251
2. Pei D. Peptide deformylase: a target for novel antibiotics?. Emerg. Ther. Targets 5 (2001) 23-40
3. Yuan Z., Trias J., and White R.J. Deformylase as a novel antibacterial target. Drug Discov. Today 6 (2001) 954-961
4. Adams J.M., and Capecchi M.R. N-formylmethionyl-sRNA as the initiator of protein synthesis. Proc. Natl. Acad. Sci. 55 (1966) 147-155
5. Groche D., Becker A., Schlichting I., Kabsch W., Schultz S., and Wagner A.F. Isolation and crystallization of functionally competent Escherichia coli Peptide deformylase forms containing either Iron or Nickel in the active site. Biochem. Biophys. Res. Commun. 246 (1998) 342-346
6. Becker A., Schlichting I., Kabsch W., Schultz S., and Wagner A.F.V. Structure of Peptide deformylase and identification of the substrate binding site. J. Biol. Chem. 273 (1998) 11413-11416
7. Davies S.J., Ayscough A.P., Beckett R.P., Bragg R.A., Clements J.M., Doel S., Grew C., Launchbury S.B., Perkins G.M., Pratt L.M., Smith H.K., Spavold Z.M., Thomas S.W., Todd R.S., and Whittaker M. Structure-activity relationships of the Peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1′ side chain. Bioorg. Med. Chem. Lett. 13 (2003) 2709-2713
8. Grant S.K., Green B.G., and Kozarich J.W. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial Peptide deformylase. Bioorg. Chem. 29 (2001) 211-222
9. Smith H.K., Beckett R.P., Clements J.M., Doel S., East S.P., Launchbury S.B., Pratt L.M., Spavold Z., Thomas W., Todd R.S., and Whittaker M. Structure-activity relationships of the Peptide deformylase inhibitor BB-3497: modification of the metal binding group. Bioorg. Med. Chem. Lett. 12 (2002) 3595-3599
10. Davies S.J., Ayscough A.P., Beckett R.P., Clements J.M., Doel S., Pratt L.M., Spavold Z.M., Thomas S.W., and Whittaker M. Structure-activity relationships of the Peptide deformylase inhibitor BB-3497: modification of the P2′ and P3′ side chains. Bioorg. Med. Chem. Lett. 13 (2003) 2715-2718
11. RSCB Protein Data Bank, web address: http://www.rscb.org/pdb/.
12. Web address: http://www.scripps.edu/mb/olson/doc/autodock/.
13. SYBYL modeling software, V7.0, Tripos Associates.
14. Weiner S.J., Kollman P.A., Case D.A., Singh U.C., Ghio C., Alagona G., Profeta S., and Weiner P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 106 (1984) 765-784
15. Musiani F., Arnofi E., Casadio R., and Ciurli S. J. Biol. Inorg. Chem. 6 (2001) 300-314
16. 6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective Peptide deformylase inhibitors. J. Med. Chem. 44 (2001) 1847-1852
17. Howard M.H., Cenizal T., Gutteridge S., Hanna W.S., Tao Y., Totrov M., Wittenbach V.A., and Zheng Y.J. A novel class of inhibitors of Peptide deformylase discovered through high-throughput screening and virtual ligand screening. J. Med. Chem. 47 (2004) 6669-6672
18. Jayasekera M.M.K., Kendall A., Shammas R., Dermyer M., Tomala M., Shapiro M.A., and Holler T.P. Novel nonpeptidic inhibitors of Peptide deformylase. Arch. Biochem. Biophys. 381 (2000) 313-316
19. Meinnel T., Patiny L., Ragusa S., and Blanquet S. Design and synthesis of substrate analogue inhibitors of Peptide deformylase. Biochemistry 38 (1999) 4287-4295
20. Chen D.Z., Patel D.V., Hackbarth C.J., Wang W., Dreyer G., Young D.C., Margolis P.S., Wu C., Ni Z.J., Trias J., White R.J., and Yuan Z. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry 39 (2000) 1256-1262
21. Jones R.N., Fritsche T.R., and Sader H.S. Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1837 recent Gram-positive clinical isolates. Diagn. Microbiol. Infect. Dis. 49 (2004) 63-65
22. Jones R.N., Sader H.S., and Fritsche T.R. Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis). Diagn. Microbiol. Infect. Dis. 51 (2005) 139-141
23. Chae P.S., Kim M.S., Jeung C.S., Lee S.D., Park H., Lee S., and Suh J. Peptide-cleaving catalyst selective for Peptide deformylase. J. Am. Chem. Soc. 127 (2005) 2396
24. Dardel F., Ragusa S., Blanquet C.L.S., and Meinnel T. Solution structure of Nickel-Peptide deformylase. J. Mol. Biol. 280 (1998) 501-513
25. Beckett R.P., Davidson A.H., Drummond A.H., Huxley P., and Whittaker M. Recent advances in matrix metalloproteinase inhibitor research. Drug Discov. Today 1 (1996) 16-26
26. East S.P., Beckett R.P., Brookings D.C., Clements J.M., Doel S., Keavey K., Pain G., Smith H.K., Thomas W., Thompson A.J., Todd R.S., and Whittaker M. Peptide deformylase inhibitors with activity against respiratory tract pathogens. Bioorg. Med. Chem. Lett. 14 (2004) 59-62
27. Clements J.M., Beckett R.P., Brown A., Catlin G., Lobell M., Palan S., Thomas W., Whittaker M., Wood S., Salama S., Baker P.J., Rodgers H.F., Barymin V., Rice D.W., and Hunter M.G. Antibiotic activity and characterization of BB-3497, a novel Peptide deformylase inhibitor. Antimicrob. Agents Chemother. 45 (2001) 563-570
28. Guilloteau J.P., Mathieu M., Giglione C., Blanc V., Dupuy A., Chevrier M., Gil P., Famechon A., Meinnel T., and Mikol V. The crystal structures of four Peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents. J. Mol. Biol. 320 (2002) 951-962
29. Ragusa S., Mouchet P., Lazennec C., Dive V., and Meinnel T. Substrate recognition and selectivity of Peptide deformylase. Similarities and differences with metzincins and thermolysin. J. Mol. Biol. 289 (1999) 1445-1457